The role of voltage-gated calcium channels in neurotransmitter phenotype specification: Coexpression and functional analysis in Xenopus laevis.

TitleThe role of voltage-gated calcium channels in neurotransmitter phenotype specification: Coexpression and functional analysis in Xenopus laevis.
Publication TypeJournal Article
Year of Publication2014
AuthorsLewis BB, Miller LE, Herbst WA, Saha MS
JournalJ Comp Neurol
Volume522
Issue11
Pagination2518-31
Date Published2014 Aug 01
ISSN1096-9861
KeywordsAction Potentials, Animals, Brain, Calcium, Calcium Channels, Calcium Channels, N-Type, Cells, Cultured, Cranial Nerves, GABAergic Neurons, gamma-Aminobutyric Acid, Glutamic Acid, In Situ Hybridization, Fluorescence, Neurons, Neurotransmitter Agents, Retina, Spinal Cord, Vesicular Glutamate Transport Protein 1, Vesicular Inhibitory Amino Acid Transport Proteins, Xenopus laevis, Xenopus Proteins
Abstract

Calcium activity has been implicated in many neurodevelopmental events, including the specification of neurotransmitter phenotypes. Higher levels of calcium activity lead to an increased number of inhibitory neural phenotypes, whereas lower levels of calcium activity lead to excitatory neural phenotypes. Voltage-gated calcium channels (VGCCs) allow for rapid calcium entry and are expressed during early neural stages, making them likely regulators of activity-dependent neurotransmitter phenotype specification. To test this hypothesis, multiplex fluorescent in situ hybridization was used to characterize the coexpression of eight VGCC α1 subunits with the excitatory and inhibitory neural markers xVGlut1 and xVIAAT in Xenopus laevis embryos. VGCC coexpression was higher with xVGlut1 than xVIAAT, especially in the hindbrain, spinal cord, and cranial nerves. Calcium activity was also analyzed on a single-cell level, and spike frequency was correlated with the expression of VGCC α1 subunits in cell culture. Cells expressing Cav 2.1 and Cav 2.2 displayed increased calcium spiking compared with cells not expressing this marker. The VGCC antagonist diltiazem and agonist (-)BayK 8644 were used to manipulate calcium activity. Diltiazem exposure increased the number of glutamatergic cells and decreased the number of γ-aminobutyric acid (GABA)ergic cells, whereas (-)BayK 8644 exposure decreased the number of glutamatergic cells without having an effect on the number of GABAergic cells. Given that the expression and functional manipulation of VGCCs are correlated with neurotransmitter phenotype in some, but not all, experiments, VGCCs likely act in combination with a variety of other signaling factors to determine neuronal phenotype specification.

DOI10.1002/cne.23547
Alternate JournalJ. Comp. Neurol.
PubMed ID24477801
PubMed Central IDPMC4043876
Grant ListR15 HD077624 / HD / NICHD NIH HHS / United States
R15 NS067566 / NS / NINDS NIH HHS / United States
R15HD077624-01 / HD / NICHD NIH HHS / United States
R15NS067566 / NS / NINDS NIH HHS / United States

Person Type: